Abstract:Kaposi's sarcoma herpesvirus (KSHV) is a leading cause of malignancy in AIDS and current therapies are limited. Like all herpesviruses, KSHV infection can be latent or lytic. KSHV latency-associated nuclear antigen (LANA) is essential for viral genome persistence during latent infection. LANA also maintains latency by antagonizing expression and function of the KSHV lytic switch protein, RTA. Here, we find LANA null KSHV is not capable of lytic replication, indicating a requirement for LANA. While LANA promoted both lytic and latent gene expression in cells partially permissive for lytic infection, it repressed expression in non-permissive cells. Importantly, forced RTA expression in non-permissive cells led to induction of lytic infection and LANA switched to promote, rather than repress, most lytic viral gene expression. When basal viral gene expression levels were high, LANA promoted expression, but repressed expression at low basal levels unless RTA expression was forcibly induced. LANA's effects were broad, but virus gene specific, extending to an engineered, recombinant viral GFP under control of host EF1α promoter, but not to host EF1α. Together, these results demonstrate that, in addition to its essential role in genome maintenance, LANA broadly regulates viral gene expression, and is required for high levels of lytic gene expression during lytic infection. Strategies that target LANA are expected to abolish KSHV infection. Kaposi's sarcoma herpesvirus (KSHV) is a leading cause of cancer in those with AIDS and current therapies are limited. Like other herpesviruses, KSHV infects cells in two forms, causing latent or lytic infection. KSHV latency-associated nuclear antigen (LANA) is essential for viral latency since it maintains the extrachromosomal viral genome in dividing cells. LANA also maintains latency by antagonizing the KSHV lytic switch protein, RTA, which is capable of triggering lytic replication. Here, we find KSHV lacking LANA is incapable of lytic infection, indicating LANA is required for lytic replication. Further, LANA can have dual effects on viral gene expression. In cells partially permissive for lytic KSHV infection, LANA promoted viral gene expression, but repressed expression in non-permissive cells. Forced RTA expression in non-permissive cells led to LANA switching to promote, rather than repress, most lytic viral gene expression. We found when basal viral gene expression levels were high, LANA promoted expression, while LANA repressed expression at low basal levels. These results show that, in addition to its essential role in genome maintenance, LANA is required for the elevated levels of lytic gene expression that occur during lytic infection. Future approaches that inactivate LANA are expected to abolish KSHV infection.

Correction for Lu Et Al., “Latency-Associated Nuclear Antigen of Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) Upregulates Survivin Expression in KSHV-Associated B-Lymphoma Cells and Contributes to Their Proliferation”

The RBP-Jκ binding sites within the RTA promoter regulate KSHV latent infection and cell proliferation.

Correction: Transactivation of human endogenous retrovirus K (HERV-K) by KSHV promotes Kaposi's sarcoma development

Upregulation Of Cellular Bcl-2 By The Kshv Encoded Rta Promotes Virion Production

Kaposi'S Sarcoma-Associated Herpesvirus Inhibits Interleukin-4-Mediated Stat6 Phosphorylation to Regulate Apoptosis and Maintain Latency

The Chromatin Modification by Sumo-2/3 but Not Sumo-1 Prevents the Epigenetic Activation of Key Immune-Related Genes During Kaposi'S Sarcoma Associated Herpesvirus Reactivation

Analysis of the ubiquitin-modified proteome identifies novel host factors in Kaposi’s sarcoma herpesvirus lytic reactivation

Nuclear Localization and Cleavage of STAT6 is Induced by Kaposi's Sarcoma-Associated Herpesvirus for Viral Latency.

Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress

The Single RBP-Jκ Site Within the LANA Promoter is Crucial for Establishing Kaposi's Sarcoma-Associated Herpesvirus Latency During Primary Infection

Regulation of viral and cellular gene expression by Kaposi's sarcoma-associated herpesvirus polyadenylated nuclear RNA

Epstein-Barr Virus Nuclear Antigen 1 (ebna1) Confers Resistance to Apoptosis in Ebv-Positive B-Lymphoma Cells Through Up-Regulation of Survivin

KSHV ORF20 Promotes Coordinated Lytic Reactivation for Increased Infectious Particle Production

Proteomic Profiling Identifies the SIM-associated Complex of KSHV-encoded LANA.

Correction for Lin Et Al., “Epstein-Barr Virus-Encoded Latent Membrane Protein 2A Promotes the Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma Via Metastatic Tumor Antigen 1 and Mechanistic Target of Rapamycin Signaling Induction”

Proteomic Profiling Identifies Kaposi's Sarcoma-Associated Herpesvirus (KSHV)-Encoded LANA(SIM)-Associated Proteins in Hypoxia

Viral activation of MK2-hsp27-p115RhoGEF-RhoA signaling axis causes cytoskeletal rearrangements, p-body disruption and ARE-mRNA stabilization

Proteomic Profiling Identifies Kaposi's Sarcoma-Associated Herpesvirus (KSHV)-Encoded LANASIM-Associated Proteins in Hypoxia

Quantitative RNAseq analysis of Ugandan KS tumors reveals KSHV gene expression dominated by transcription from the LTd downstream latency promoter

Mapping herpesvirus-driven impacts on the cellular milieu and transcriptional profile of Kaposi sarcoma in patient-derived mouse models

Kaposi's sarcoma herpesvirus latency-associated nuclear antigen broadly regulates viral gene expression and is essential for lytic infection